Document:

Exhibit 10.35

 

WAIVER AND CONSENT

 

This Waiver and Consent (“Consent”)
is made and entered into as of December 13, 2022, by 6D Dental Limited (the “Holder”) in connection with the Promissory
Note attached hereto as Exhibit A (the “Promissory Note”) and Stock Subscription Agreement attached hereto as
Exhibit B (the “Stock Subscription Agreement”) entered into between Etao International Group, a Cayman Islands
corporation (the “Parent”), Etao International Healthcare Technology Co., Ltd. (the “WFOE”), and
the Holder. Capitalized terms used but not defined herein will have the meanings assigned to them in the Promissory Note and the Stock
Subscription Agreement, respectively.

 

WHEREAS, the Parent and WFOE entered into the Promissory
Note dated as of August 24, 2021, whereby the Parent and WFOE will jointly and severally, and unconditionally promise to pay to the order
of Holder, the principal amount of $1,726,153.85 USD (the “Principal Amount”), together with the accrued interest at
the rate of 2% per annum; and

 

WHEREAS, the the Parent and WFOE wish to request
a waiver of Section 1(b) of the Promissory Note and Section 2.2(a) of the Stock Subscription Agreement by the Holder of the Holder’s
right to request the prepayment of the Promissory Note, upon completion of the DeSpac Merger between Mountain Crest Acquisition Corp.
III, a Delaware corporation, and the Parent.

 

NOW, THEREFORE, the Holder hereby agrees as follows:

 

1.       The
Holder hereby agrees to waive its right to demand prepayments of the Promissory Note pursuant to Section 1(b) of the Promissory Note,
as set forth below:

 

“b) Mandatory Prepayments. Upon the
completion of the DeSPAC Merger, the Holder shall have the right to request the repayment of the Note, in whole or in part, on or after
the date (“Mandatory Prepayment Triggering Date”) that is thirty (30) calendar days from the consummation of the DeSPAC Merger,
provided that the Mandatory Prepayment Triggering Date occurs prior to the Maturity Date.”

 

2.       The
Holder hereby agrees to waive its right to demand prepayments of the Stock Subscription Agreement pursuant to Section 2.2(a) of the Stock
Subscription Agreement, as set forth below:

 

(a)       The total Purchase Price for the aggregate Sale Shares shall be $6,939,000.00, 20% of which shall be payable in promissory notes
(each, a “Promissory Note” and collectively, the “Promissory Notes”), substantially in the form attached hereto
as Exhibit A, to be issued by the Parent upon Closing to each and all of the Sellers, in the sum of $1,387,800, and 80% which shall
be payable in Class A ordinary shares of the Parent (the “Parent Ordinary Shares”), par value $0.01 per share, in the total
amount of [] Parent Ordinary Shares (the “Stock Consideration”) at a per share price of $10.00, to the Sellers in the respective
amounts as set forth in Annex A. Subject to the terms and conditions of the Promissory Notes, such Notes shall have a term of three
(3) years from the Closing Date, bear an interest of 2% per annum and be unsecured.

 

3.       The
invalidity or unenforceability of any provision hereof will in no way affect the validity or enforceability of any other provision.

 

    1

    

    

 

4.       All
notices, demands, requests, consents, approvals, and other communications required or permitted in connection with this Consent shall
be made and given in the same manner set forth in Section 4(a) of the Promissory Note and Section 14.4 of the Stock Subscription Agreement.

 

5.       This
Consent shall be governed by, interpreted and construed in accordance with the laws of the State of New York without regard to principles
of conflicts of laws and as further described in Section 4(k) of the Promissory Note and Section 14.14 of the Stock Subscription Agreement.

 

(Signatures to follow)

 

    2

    

    

 

IN WITNESS
WHEREOF, the Holder has caused this Waiver to be executed as of the date first written above.

 

	 	Holder
	 	6D Dental Limited
	 	 
	 	 
	 	By:	\s\
    Jia You
	 	Name: 	Jia You
	 	Title: 	Director and CEO

 

    3

    

    

 

EXHIBIT A 

 

PROMISSORY NOTE

 

    4

    

    

 

EXHIBIT B 

 

STOCK SUBSCRIPTION AGREEMENT

 

    5Exhibit 10.1

 

FORM OF NON-REDEMPTION AGREEMENT

 

	SPAC:	Williams Rowland Acquisition Corporation, a Delaware Corporation (“SPAC”).

 

	Sponsors:	Williams Rowland Sponsor LLC
	 	Wrac Ltd.

 

	Investor:	[  ]

 

	Investor Agreements:	Investor represents that it owns as of December 2, 2022, the record date for the SPAC’s special meeting to be held on December 22, 2022, with respect to the SPAC’s stockholder vote in connection with amendments of SPAC’s Amended and Restated Certificate of Incorporation and the Trust Agreement to extend the date by which the SPAC must consummate an initial business combination by six months (the “Extension”), [  ] shares of the common stock, par value $0.0001 per share (the “Investor Shares”).
	 	 
	 	Investor waives any right that it may have to elect to have SPAC redeem any Investor Shares and agrees not to redeem or otherwise exercise any right to redeem, the Investor Shares and to reverse and revoke any prior redemption elections made with respect to the Investor Shares in connection with the Extension.
	 	 
	 	Investor agrees that neither it, nor any person or entity acting on its behalf or pursuant to any understanding with it, will, from the execution of this Agreement until the business day following a successful stockholder vote with respect to the Extension, (a) engage in any hedging transactions or Short Sales (as defined below) with respect to securities of SPAC, (b) offer for sale, sell (including Short Sales), transfer (including by operation of law), place a lien on, pledge, convert, assign or otherwise dispose of (including by gift, merger, tendering into any tender offer or exchange offer or otherwise) or encumber (collectively, a “Transfer”), or enter into any contract, option, derivative, hedging or other agreement, arrangement, undertaking or understanding (including any profit-sharing arrangement) with respect to, or consent to, a direct or indirect Transfer of, any or all of the Investor Shares, or (c) take any action that would have the effect of preventing or materially delaying the performance of its obligations hereunder. For purposes of this agreement (this “Agreement”), “Short Sales” shall include, without limitation, (i) all “short sales” as defined in Rule 200 promulgated under Regulation SHO under the Exchange Act, (ii) all types of direct and indirect stock pledges (other than pledges in the ordinary course of business as part of prime brokerage or other similar financing arrangements), forward sale contracts, options, puts, calls, swaps and similar arrangements (including on a total return basis), and (iii) sales and other transactions through non-U.S. broker dealers or foreign regulated brokers.
	 	 
	 	Investor agrees that it will and will cause its controlled affiliates to vote (or cause to be voted) or execute and deliver a written consent (or cause a written consent to be executed and delivered) all of the Investor Shares owned, as of the applicable record date, by any of them at any meeting of the stockholders of the SPAC in favor of the Extension and cause all such shares to be counted as present thereat for purposes of establishing a quorum.

 

     

     

    

 

	Transferred Sponsor Shares:	_______ fully paid, non-assessable SPAC Shares currently held of record by the Sponsors (the “Transferred Sponsor Shares”) calculated as 15,000 Transferred Sponsor Shares per each 99,000 of Investor Shares.
	 	 
	SPAC and Sponsor Agreements:	Subject to the compliance of the Investor with the agreements and representations herein and conditioned on the consummation of the Extension, the Sponsor agrees to issue to the Investor the Transferred Sponsor Shares on or promptly after the consummation of the SPAC’s business combination. The SPAC will not make any amendments to the terms of the Transferred Sponsor Shares stated in the IPO prospectus dated July 26, 2021. The Transferred Sponsor Shares will not be subject to any earn-out, cut-back, reduction, mandatory repurchase, redemption, forfeiture or transfer restriction not described here or in the IPO prospectus, without the Investor’s prior written consent.
	 	 
	Trust Account:	Until the earlier of (a) the consummation of SPAC’s initial business combination; (b) the liquidation of the Trust Account; and (c) two business days prior to the 24 month anniversary of the consummation of SPAC’s initial public offering, SPAC will maintain the investment of funds held in the Trust Account in interest-bearing United States government securities within the meaning of Section 2(a)(16) of the Investment Company Act of 1940, as amended, having a maturity of 185 days or less, or in money market funds meeting the conditions of paragraphs (d)(1), (d)(2), (d)(3) and (d)(4) of Rule 2a-7 promulgated under the Investment Company Act of 1940, as amended, which invest only in direct U.S. government treasury obligations. SPAC further confirms that it will not utilize any funds from its Trust Account to pay any potential excise taxes that may become due upon a redemption of the Public Shares, including in connection with a liquidation of SPAC if it does not effect a business combination prior to its termination date. Notwithstanding the foregoing, this will not prevent the SPAC from receiving interest to pay income and franchise taxes as permitted by and in accordance with its Investment Management Trust Agreement with Continental Stock Transfer & Trust Company.

 

	MFN:	SPAC will not enter into any similar agreement with any other investor in connection with the meeting at which the Extension will
be considered (each, an “Other Transaction”) with any terms or conditions more favorable to the parties in such Other Transaction
than the terms and conditions set forth herein. If, and whenever on or after the date hereof, SPAC enters into an Other Transaction, then
(i) the SPAC shall provide notice thereof to the Investor immediately following the occurrence thereof and (ii) in addition to any other
remedies of the Investor in law or equity, the terms and conditions of this agreement shall be, without any further action by the Seller
or the Counterparty, automatically amended and modified in an economically and legally equivalent manner such that the Seller shall receive
the benefit of the more favorable terms and/or conditions (as the case may be) set forth in such Other Transaction.

 

    2

     

    

 

	Investor Representations and Warranties:	Investor represents and warrants to SPAC and Sponsors the representations and warranties on Exhibit A hereto.
	 	 
	Termination Event:	This Agreement and all of its provisions shall terminate and be of no further force or effect upon the earliest to occur of (a) the mutual written consent of the parties hereto, (b) the consummation of the Extension and the delivery of the Transferred Sponsor Shares to the Investor, and (c) December 31, 2022.

 

	Disclosure:	SPAC shall promptly following the execution of this Agreement adequately discloses the material terms and conditions of the transaction
contemplated by this Agreement. SPAC shall not name Investor in such disclosure unless required by applicable law or regulation.

 

	Governing Law and Jurisdiction:	New York
	 	 
	Trust Account Waiver:	Investor acknowledges that SPAC has established a trust account (the “Trust Account”) containing the proceeds of its initial public offering (“IPO”) and certain proceeds of the private placement (including interest accrued from time to time thereon) for the benefit of its public stockholders and certain other parties (including the underwriters of the IPO). For good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Investor hereby agrees (on its own behalf and on behalf of its related parties) that it does not now and shall not at any time hereafter have any right, title, interest or claim of any kind in or to any assets held in the Trust Account, and it shall not make any claim against the Trust Account, regardless of whether such claim arises as a result of, in connection with or relating in any way to this Agreement or any other matter, and regardless of whether such claim arises based on contract, tort, equity or any other theory of legal liability (any and all such claims are collectively referred to hereafter as the “Released Claims”); provided, that the Released Claims shall not include any rights or claims of the Investor or any of its related parties as a shareholder of SPAC to the extent related to or arising from any shares of the SPAC.
	 	 
	Entire Agreement:	This Agreement and the agreements referenced herein constitute the entire binding agreement and understanding of the parties hereto in respect of the subject matter hereof and supersede all prior understandings, agreements or representations by or among the parties hereto to the extent that they relate in any way to the subject matter hereof.

 

[SIGNATURES ON FOLLOWING PAGE]

 

    3

     

    

 

	[Investor Entity]	 	WILLIAMS ROWLAND ACQUISITION CORP.
	 	 	 
	By:	    	 	By:	               
	Name:	 	 	Name:	 
	Title:	 	 	Title:	 

 

	WILLIAMS ROWLAND SPONSOR LLC
	 	 
	By:	         	 
	Name:	 	 
	Title:	 	 
	 	 	 
	WRAC LTD	 
	 	 
	Name:	 	 
	Title:	 	 

 

Please provide exact names of holders of Investor Shares as of December
2, 2022, together with number of shares held by each:

 

______________________________

 

     

     

    

 

EXHIBIT A

 

(a) This Agreement has been duly executed and delivered by the Investor
and, assuming due authorization, execution and delivery by Sponsors and SPAC, this Agreement constitutes a legally valid and binding obligation
of the Investor, enforceable against the Investor in accordance with the terms hereof (except as enforceability may be limited by bankruptcy
laws, other similar laws affecting creditors’ rights and general principles of equity affecting the availability of specific performance
and other equitable remedies).

 

(b) The execution and delivery of this Agreement by the Investor does
not, and the performance by the Investor of its obligations hereunder will not, (i) conflict with or result in a violation of the organizational
documents of the Investor or (ii) require any consent or approval that has not been given or other action that has not been taken by any
person, in each case to the extent such consent, approval or other action would prevent, enjoin or materially delay the performance by
the Investor of its obligations under this Agreement.

 

(c) The Investor (i) is a “qualified institutional buyer”
(as defined in Rule 144A under the Securities Act) or an institutional “accredited investor” (within the meaning of Rule 501(a)(1),
(2), (3) or (7) under the Securities Act), in each case, satisfying the applicable requirements set forth on Annex A, (ii) is acquiring
any Transferred Sponsor Shares that may be issued to the Investor pursuant to this Agreement only for its own account and not for the
account of others, or if the Investor is acquiring any Transferred Sponsor Shares that may be issued to the Investor pursuant to this
Agreement as a fiduciary or agent for one or more investor accounts, each owner of such account is a qualified institutional buyer or
institutional accredited investor (as the case may be) and the Investor has full investment discretion with respect to each such account,
and the full power and authority to make the acknowledgements, representations and agreements herein on behalf of each owner of each such
account, and (iii) is not acquiring any Transferred Sponsor Shares that may be issued to the Investor pursuant to this Agreement with
a view to, or for offer or sale in connection with, any distribution thereof in violation of the Securities Act (and shall provide the
requested information on Annex A). The Investor is not an entity formed for the specific purpose of acquiring any Transferred Sponsor
Shares that may be issued to the Investor pursuant to this Agreement, unless such newly formed entity is an entity in which all of the
investors are institutional accredited investors, and is an “institutional account” as defined by FINRA Rule 4512(c). The
Investor is a sophisticated institutional investor, experienced in investing in private equity transactions and capable of evaluating
investment risks independently, both in general and with regard to all transactions and investment strategies involving a security or
securities. Accordingly, the Investor understands that the acquisition of any Transferred Sponsor Shares that may be issued to the Investor
pursuant to this Agreement meets (i) the exemptions from filing under FINRA Rule 5123(b)(1)(A) and (ii) the institutional customer exemption
under FINRA Rule 2111(b).

 

(d) The Investor understands that any Transferred Sponsor Shares that
may be issued to the Investor pursuant to this Agreement are being offered in a transaction not involving any public offering within the
meaning of the Securities Act and that the Transferred Sponsor Shares have not been registered under the Securities Act. The Investor
understands that the Transferred Sponsor Shares may not be offered, resold, transferred, pledged or otherwise disposed of by the Investor
absent an effective registration statement under the Securities Act, except pursuant to an applicable exemption from the registration
requirements of the Securities Act, and in accordance with any applicable securities laws of the applicable states and other jurisdictions
of the United States, and that any certificates or book entry records representing the Transferred Sponsor Shares shall contain a restrictive legend to such
effect. The Investor acknowledges and agrees that the Transferred Sponsor Shares will be subject to these securities law transfer restrictions
and, as a result of these transfer restrictions, the Investor may not be able to readily resell the Transferred Sponsor Shares and may
be required to bear the financial risk of an investment in the Transferred Sponsor Shares for an indefinite period of time. The Investor
understands that it has been advised to consult legal counsel prior to making any offer, resale, pledge or transfer of any of the Transferred
Sponsor Shares.

 

     

     

    

 

(e) In making its decision to invest in the Transferred Sponsor Shares,
the Investor has relied solely upon independent investigation made by the Investor and Sponsors’ and SPAC’s representations,
warranties and covenants contained herein. The Investor has not relied on any statements or other information provided by anyone other
than SPAC concerning SPAC, the Transferred Sponsor Shares or the offer of the Transferred Sponsor Shares. The Investor acknowledges and
agrees that the Investor has received such information as the Investor deems necessary in order to make an investment decision with respect
to the Transferred Sponsor Shares and made its own assessment and is satisfied concerning the relevant tax and other economic considerations
relevant to the Investor’s investment in the Transferred Sponsor Shares. The Investor represents and agrees that the Investor and
the Investor’s professional advisor(s), if any, have had the full opportunity to ask such questions, receive such answers and obtain
such information as the Investor and its professional advisor(s), if any, have deemed necessary to make an investment decision with respect
to the Transferred Sponsor Shares. Without limiting the generality of the foregoing, the Investor acknowledges that it has had an opportunity
to review the reports publicly filed with the Securities and Exchange Commission.

 

(f) Investor became aware of the offering of the Transferred Sponsor
Shares solely by means of direct contact between the Investor, Sponsors, SPAC or their representatives or affiliates. The Investor did
not become aware of the offering of the Transferred Sponsor Shares, nor were the Transferred Sponsor Shares offered to the Investor, by
any other means. The Investor acknowledges that Transferred Sponsor Shares (i) were not offered by any form of general solicitation or
general advertising and (ii) are not being offered in a manner involving a public offering under the Securities Act or any state securities
laws.

 

(g) Investor acknowledges that it is aware that there are substantial
risks incident to the ownership of the Transferred Sponsor Shares. The Investor has such knowledge and experience in financial and business
matters as to be capable of evaluating the merits and risks of an investment in the Transferred Sponsor Shares, and the Investor has had
an opportunity to seek, and has sought, such accounting, legal, business and tax advice as the Investor has considered necessary to make
an informed investment decision. The Investor is not relying on any statements or representations of Sponsors, SPAC or any of its agents
for legal, tax or investment advice with respect to this Agreement or the transactions contemplated by the Agreement. The Investor has
fully considered the risks of an investment in the Transferred Sponsor Shares and determined that the Transferred Sponsor Shares are a
suitable investment for the Investor and that the Investor is able at this time and in the foreseeable future to bear the economic risk
of a total loss of the Investor’s investment in the Transferred Sponsor Shares. The Investor acknowledges specifically that a possibility
of total loss exists.

 

(h) The Investor understands and agrees that no federal or state agency
has passed upon or endorsed the merits of the offering of the Transferred Sponsor Shares or made any findings or determination as to the
fairness of this investment.

 

(i) No broker or finder has acted on behalf of the Investor in such
a way as to create any liability on Sponsors or SPAC in connection with this Agreement.

 

(j) The Investor is not entering into the transactions contemplated
by this Agreement to create actual or apparent trading activity in any security of the SPAC (or any security convertible into or exchangeable
for a security of the SPAC) or to raise or depress or otherwise manipulate the price of any security of the SPAC (or any security convertible
into or exchangeable for a security of the SPAC) or otherwise in violation of the Exchange Act. The Investor has not entered into or altered,
and agrees that the Investor will not enter into or alter, any corresponding or hedging transaction or position with respect to any security
of the SPAC.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00351-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00351-of-00352.parquet"}]]